• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米神经诊疗学:纳米颗粒对神经功能障碍的影响以及降低毒性以提高疗效的策略。

Nano-Neurotheranostics: Impact of Nanoparticles on Neural Dysfunctions and Strategies to Reduce Toxicity for Improved Efficacy.

作者信息

Vinod Chiluka, Jena Srikanta

机构信息

Department of Biological Sciences, School of Applied Sciences, KIIT University, Bhubaneswar, India.

Department of Zoology, School of Life Sciences, Ravenshaw University, Cuttack, India.

出版信息

Front Pharmacol. 2021 Mar 26;12:612692. doi: 10.3389/fphar.2021.612692. eCollection 2021.

DOI:10.3389/fphar.2021.612692
PMID:33841144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8033012/
Abstract

Nanotheranostics is one of the emerging research areas in the field of nanobiotechnology offering exciting promises for diagnosis, bio-separation, imaging mechanisms, hyperthermia, phototherapy, chemotherapy, drug delivery, gene delivery, among other uses. The major criteria for any nanotheranostic-materials is 1) to interact with proteins and cells without meddling with their basic activities, 2) to maintain their physical properties after surface modifications and 3) must be nontoxic. One of the challenging targets for nanotheranostics is the nervous system with major hindrances from the neurovascular units, the functional units of blood-brain barrier. As blood-brain barrier is crucial for protecting the CNS from toxins and metabolic fluctuations, most of the synthetic nanomaterials cannot pass through this barrier making it difficult for diagnosing or targeting the cells. Biodegradable nanoparticles show a promising role in this aspect. Certain neural pathologies have compromised barrier creating a path for most of the nanoparticles to enter into the cells. However, such carriers may pose a risk of side effects to non-neural tissues and their toxicity needs to be elucidated at preclinical levels. This article reviews about the different types of nanotheranostic strategies applied in nervous dysfunctions. Further, the side effects of these carriers are reviewed and appropriate methods to test the toxicity of such nano-carriers are suggested to improve the effectiveness of nano-carrier based diagnosis and treatments.

摘要

纳米诊疗学是纳米生物技术领域新兴的研究领域之一,在诊断、生物分离、成像机制、热疗、光疗、化疗、药物递送、基因递送等诸多应用方面有着令人兴奋的前景。任何纳米诊疗材料的主要标准是:1)与蛋白质和细胞相互作用而不干扰其基本活动;2)表面修饰后保持其物理性质;3)必须无毒。纳米诊疗学面临的一个具有挑战性的目标是神经系统,神经血管单元(血脑屏障的功能单元)是主要障碍。由于血脑屏障对于保护中枢神经系统免受毒素和代谢波动的影响至关重要,大多数合成纳米材料无法穿过该屏障,这使得诊断或靶向细胞变得困难。可生物降解的纳米颗粒在这方面显示出有前景的作用。某些神经病理学损害了屏障,为大多数纳米颗粒进入细胞创造了一条途径。然而,此类载体可能对非神经组织产生副作用风险,其毒性需要在临床前水平进行阐明。本文综述了应用于神经功能障碍的不同类型的纳米诊疗策略。此外,还综述了这些载体的副作用,并提出了测试此类纳米载体毒性的适当方法,以提高基于纳米载体的诊断和治疗的有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9db9/8033012/2e2f1a2e9a47/fphar-12-612692-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9db9/8033012/19d16e65926c/fphar-12-612692-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9db9/8033012/2e2f1a2e9a47/fphar-12-612692-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9db9/8033012/19d16e65926c/fphar-12-612692-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9db9/8033012/2e2f1a2e9a47/fphar-12-612692-g002.jpg

相似文献

1
Nano-Neurotheranostics: Impact of Nanoparticles on Neural Dysfunctions and Strategies to Reduce Toxicity for Improved Efficacy.纳米神经诊疗学:纳米颗粒对神经功能障碍的影响以及降低毒性以提高疗效的策略。
Front Pharmacol. 2021 Mar 26;12:612692. doi: 10.3389/fphar.2021.612692. eCollection 2021.
2
Nanobiotechnology-based drug delivery in brain targeting.基于纳米生物技术的脑靶向给药
Curr Pharm Biotechnol. 2013;14(15):1264-74. doi: 10.2174/1389201015666140608143719.
3
Nanobiotechnology-based drug delivery to the central nervous system.基于纳米生物技术的中枢神经系统药物递送
Neurodegener Dis. 2007;4(4):287-91. doi: 10.1159/000101884.
4
Nano carriers for drug transport across the blood-brain barrier.用于药物穿越血脑屏障运输的纳米载体。
J Drug Target. 2017 Jan;25(1):17-28. doi: 10.1080/1061186X.2016.1184272. Epub 2016 May 19.
5
Nanosize drug delivery system.纳米尺寸药物递送系统。
Curr Pharm Biotechnol. 2013;14(15):1221. doi: 10.2174/138920101415140804121008.
6
Nanotheranostics, a future remedy of neurological disorders.神经疾病的未来疗法——纳米诊疗剂
Expert Opin Drug Deliv. 2019 Feb;16(2):113-128. doi: 10.1080/17425247.2019.1562443. Epub 2019 Jan 7.
7
Polymeric nanoparticles for the drug delivery to the central nervous system.用于向中枢神经系统递送药物的聚合物纳米颗粒。
Expert Opin Drug Deliv. 2008 Feb;5(2):155-74. doi: 10.1517/17425247.5.2.155.
8
Nano-enabled delivery systems across the blood-brain barrier.纳米载体透过血脑屏障的递药系统。
Arch Pharm Res. 2014 Jan;37(1):24-30. doi: 10.1007/s12272-013-0272-6. Epub 2013 Oct 30.
9
Central nervous system toxicity of metallic nanoparticles.金属纳米颗粒的中枢神经系统毒性
Int J Nanomedicine. 2015 Jul 3;10:4321-40. doi: 10.2147/IJN.S78308. eCollection 2015.
10
Standardization of research methods employed in assessing the interaction between metallic-based nanoparticles and the blood-brain barrier: Present and future perspectives.评估金属基纳米粒子与血脑屏障相互作用的研究方法标准化:现状与未来展望。
J Control Release. 2019 Feb 28;296:202-224. doi: 10.1016/j.jconrel.2019.01.022. Epub 2019 Jan 18.

引用本文的文献

1
A novel degradable PEG superparamagnetic iron oxide capsule coupled with a polyphenolic nano-enzymatic conjugate (PSPM-NE), to treat ROS-driven cardiovascular-diseases, tested in atherosclerosis as a model disease, and hypothesizing autoimmunity as an atheroma's trigger.一种新型可降解聚乙二醇超顺磁性氧化铁胶囊与多酚纳米酶缀合物(PSPM-NE)相结合,用于治疗由活性氧驱动的心血管疾病,以动脉粥样硬化作为模型疾病进行测试,并假设自身免疫是动脉粥样硬化的触发因素。
Front Cardiovasc Med. 2024 Jul 2;11:1125571. doi: 10.3389/fcvm.2024.1125571. eCollection 2024.
2
Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy.与抗肿瘤化疗相关的并发症和合并症:重新思考抗癌治疗的药物设计与递送。
Acta Pharm Sin B. 2024 Jul;14(7):2901-2926. doi: 10.1016/j.apsb.2024.03.006. Epub 2024 Mar 11.
3

本文引用的文献

1
Size-dependent intranasal administration of magnetoelectric nanoparticles for targeted brain localization.基于尺寸依赖的磁电纳米粒子经鼻腔给药实现靶向脑部定位。
Nanomedicine. 2021 Feb;32:102337. doi: 10.1016/j.nano.2020.102337. Epub 2020 Nov 14.
2
Investigating the optimum size of nanoparticles for their delivery into the brain assisted by focused ultrasound-induced blood-brain barrier opening.研究在超声聚焦打开血脑屏障辅助下,将纳米颗粒递送至大脑的最佳粒径。
Sci Rep. 2020 Oct 26;10(1):18220. doi: 10.1038/s41598-020-75253-9.
3
Transport of ultrasmall gold nanoparticles (2 nm) across the blood-brain barrier in a six-cell brain spheroid model.
Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands.脑靶向药物递送 - 通过脑靶向配体将纳米囊泡递送到特定的脑细胞。
J Nanobiotechnology. 2024 May 17;22(1):260. doi: 10.1186/s12951-024-02511-7.
4
Tau- and α-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases.针对 Tau 和 α-突触核蛋白的金纳米颗粒:在神经退行性疾病的诊断和治疗中的应用、机遇和未来展望。
J Nanobiotechnology. 2024 May 13;22(1):248. doi: 10.1186/s12951-024-02526-0.
5
Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection.金纳米颗粒在神经退行性疾病中的神经保护作用研究进展
Int J Mol Sci. 2024 Feb 17;25(4):2360. doi: 10.3390/ijms25042360.
6
Human mini-blood-brain barrier models for biomedical neuroscience research: a review.用于生物医学神经科学研究的人类微型血脑屏障模型:综述
Biomater Res. 2022 Dec 16;26(1):82. doi: 10.1186/s40824-022-00332-z.
7
Roles and Mechanisms of Astragaloside IV in Combating Neuronal Aging.黄芪甲苷在对抗神经元衰老中的作用及机制
Aging Dis. 2022 Dec 1;13(6):1845-1861. doi: 10.14336/AD.2022.0126.
8
ZWZ-3, a Fluorescent Probe Targeting Mitochondria for Melanoma Imaging and Therapy.ZWZ-3,一种用于黑色素瘤成像和治疗的靶向线粒体的荧光探针。
Front Pharmacol. 2022 Feb 23;13:829684. doi: 10.3389/fphar.2022.829684. eCollection 2022.
9
Nanotechnology in Fire Protection-Application and Requirements.消防中的纳米技术——应用与要求
Materials (Basel). 2021 Dec 18;14(24):7849. doi: 10.3390/ma14247849.
10
The Effect of Oxidative Stress and Memantine-Incorporated Reactive Oxygen Species-Sensitive Nanoparticles on the Expression of -Methyl-d-aspartate Receptor Subunit 1 in Brain Cancer Cells for Alzheimer's Disease Application.氧化应激和载有美金刚的活性氧敏感纳米颗粒对用于阿尔茨海默病的脑癌细胞中N-甲基-D-天冬氨酸受体亚基1表达的影响。
Int J Mol Sci. 2021 Nov 15;22(22):12309. doi: 10.3390/ijms222212309.
六细胞脑球体模型中 2nm 超小金纳米颗粒的血脑屏障转运。
Sci Rep. 2020 Oct 22;10(1):18033. doi: 10.1038/s41598-020-75125-2.
4
Size, shape, and flexibility influence nanoparticle transport across brain endothelium under flow.尺寸、形状和柔韧性会影响纳米颗粒在流动状态下穿过脑内皮的传输。
Bioeng Transl Med. 2019 Dec 26;5(2):e10153. doi: 10.1002/btm2.10153. eCollection 2020 May.
5
Therapeutic efficacy of nanoparticles and routes of administration.纳米颗粒的治疗效果及给药途径。
Biomater Res. 2019 Nov 21;23:20. doi: 10.1186/s40824-019-0166-x. eCollection 2019.
6
Interactions of Nanoparticles and Biosystems: Microenvironment of Nanoparticles and Biomolecules in Nanomedicine.纳米颗粒与生物系统的相互作用:纳米医学中纳米颗粒与生物分子的微环境
Nanomaterials (Basel). 2019 Sep 24;9(10):1365. doi: 10.3390/nano9101365.
7
Carbon dot-protoporphyrin IX conjugates for improved drug delivery and bioimaging.碳点原卟啉 IX 缀合物用于改善药物传递和生物成像。
PLoS One. 2019 Jul 25;14(7):e0220210. doi: 10.1371/journal.pone.0220210. eCollection 2019.
8
Delivery of drugs into brain tumors using multicomponent silica nanoparticles.采用多组分硅纳米颗粒向脑肿瘤内递送药物。
Nanoscale. 2019 Jun 20;11(24):11910-11921. doi: 10.1039/c9nr02876e.
9
Intracisternal delivery of PEG-coated gold nanoparticles results in high brain penetrance and long-lasting stability.脑室内递送聚乙二醇修饰的金纳米颗粒可实现高脑穿透率和长期稳定性。
J Nanobiotechnology. 2019 Apr 3;17(1):49. doi: 10.1186/s12951-019-0481-3.
10
Golden Exosomes Selectively Target Brain Pathologies in Neurodegenerative and Neurodevelopmental Disorders.金纳米囊泡可选择性靶向神经退行性和神经发育性疾病的脑部病变。
Nano Lett. 2019 Jun 12;19(6):3422-3431. doi: 10.1021/acs.nanolett.8b04148. Epub 2019 Feb 27.